Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer
Open Access
- 24 February 2011
- Vol. 117 (17), 3889-3899
- https://doi.org/10.1002/cncr.25935
Abstract
Currently, nonsmall‐cell lung cancer (NSCLC) is the leading cause of cancer‐related death in the United States. Angiogenesis, the formation of new vasculature, is a complex and tightly regulated process that promotes metastasis and disease progression in lung cancer and other malignancies. Developmental antiangiogenic agents have shown activity in NSCLC, and bevacizumab, an antiangiogenic monoclonal antibody, is approved for the treatment of patients with advanced disease. However, predictive biomarkers are needed to guide the administration of antiangiogenic agents. It is possible that angiogenic molecules could accurately predict patient response to targeted antiangiogenic therapies, which would allow individualized and perhaps more effective treatment. Angiogenic signaling molecules may also have value as prognostic indicators, which may be useful for the management of NSCLC. Here the author provides an overview of angiogenic molecules currently being investigated as prognostic biomarkers in NSCLC and discusses their potential to guide treatment choices. Cancer 2011;. © 2011 American Cancer Society.Keywords
This publication has 98 references indexed in Scilit:
- Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patientsLung Cancer, 2010
- Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumorsMolecular Cancer Therapeutics, 2009
- MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung CancerCancer Research, 2009
- Biomarkers of response and resistance to antiangiogenic therapyNature Reviews Clinical Oncology, 2009
- The FGF family: biology, pathophysiology and therapyNature Reviews Drug Discovery, 2009
- MicroRNAs: Opening a New Vein in Angiogenesis ResearchScience Signaling, 2009
- Serum Insulin-Like Growth Factor-I and Platelet-Derived Growth Factor as Biomarkers of Breast Cancer PrognosisCancer Epidemiology, Biomarkers & Prevention, 2008
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005